| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0378 |
Hospital observation service, per hour |
1,272 |
894 |
$602K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
7,612 |
5,412 |
$435K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,690 |
3,860 |
$374K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
6,031 |
480 |
$334K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,445 |
979 |
$93K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,800 |
1,999 |
$92K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
1,348 |
737 |
$80K |
| 71046 |
Radiologic examination, chest; 2 views |
3,403 |
2,356 |
$69K |
| 87428 |
|
1,220 |
1,035 |
$55K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,678 |
1,666 |
$53K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,405 |
160 |
$48K |
| 71045 |
Radiologic examination, chest; single view |
2,179 |
1,184 |
$47K |
| 80053 |
Comprehensive metabolic panel |
7,031 |
4,318 |
$45K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,581 |
5,466 |
$43K |
| 70450 |
Computed tomography, head or brain; without contrast material |
657 |
381 |
$25K |
| A0425 |
Ground mileage, per statute mile |
932 |
512 |
$24K |
| 36415 |
Collection of venous blood by venipuncture |
10,351 |
6,532 |
$20K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
264 |
226 |
$20K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
263 |
185 |
$19K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
140 |
109 |
$19K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
173 |
58 |
$15K |
| 81007 |
|
1,077 |
848 |
$15K |
| 84484 |
|
2,445 |
1,366 |
$15K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
197 |
179 |
$14K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
126 |
64 |
$11K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
440 |
278 |
$10K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
205 |
171 |
$9K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
74 |
38 |
$7K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
483 |
385 |
$7K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,118 |
819 |
$6K |
| 87276 |
|
453 |
398 |
$6K |
| 74178 |
|
18 |
12 |
$5K |
| 83880 |
|
229 |
158 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
109 |
85 |
$4K |
| 64483 |
|
16 |
12 |
$3K |
| 86403 |
|
396 |
348 |
$3K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
319 |
270 |
$3K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
64 |
57 |
$3K |
| 64493 |
|
30 |
26 |
$3K |
| 87088 |
|
860 |
698 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
341 |
283 |
$3K |
| 93271 |
|
70 |
27 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
87 |
69 |
$3K |
| 83735 |
|
875 |
537 |
$2K |
| 74018 |
|
74 |
40 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
384 |
304 |
$2K |
| 80061 |
Lipid panel |
344 |
260 |
$2K |
| 73560 |
|
116 |
71 |
$1K |
| 62323 |
|
26 |
24 |
$1K |
| 93041 |
|
64 |
15 |
$1K |
| 64450 |
|
20 |
12 |
$1K |
| 81003 |
|
691 |
529 |
$1K |
| 96376 |
|
341 |
152 |
$1K |
| 72100 |
|
14 |
14 |
$993.15 |
| G0379 |
Direct admission of patient for hospital observation care |
172 |
137 |
$556.48 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
14 |
12 |
$549.08 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
105 |
97 |
$543.86 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
94 |
80 |
$513.72 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
15 |
12 |
$410.54 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
15 |
12 |
$410.54 |
| 82728 |
|
37 |
33 |
$329.09 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
16 |
12 |
$325.60 |
| 81025 |
|
40 |
37 |
$224.75 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
804 |
584 |
$170.93 |
| 83690 |
|
14 |
13 |
$62.00 |
| 74019 |
|
19 |
12 |
$59.35 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
115 |
67 |
$39.60 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
18 |
13 |
$10.80 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
547 |
463 |
$7.20 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
248 |
203 |
$0.00 |